Literature DB >> 22439918

Mycobacterium genavense in the Netherlands: an opportunistic pathogen in HIV and non-HIV immunocompromised patients. An observational study in 14 cases.

W Hoefsloot1, J van Ingen, E J G Peters, C Magis-Escurra, P N R Dekhuijzen, M J Boeree, D van Soolingen.   

Abstract

Mycobacterium genavense is an opportunistic non-tuberculous mycobacterium previously mostly associated with HIV-infected patients with CD4 counts below 100/μL. In this retrospective observational study of medical charts we studied all Dutch patients in whom M. genavense was detected between January 2002 and January 2010. Of the 14 patients identified, 13 (93%) showed clinically relevant M. genavense disease. All patients with M. genavense disease were severely immunocompromised, including HIV-infected patients, solid organ transplant recipients, those with chronic steroid use in combination with other immune modulating drugs, recipients of chemotherapy for non-Hodgkin lymphoma, and those with immunodeficiency syndromes. Two patients had non-disseminated pulmonary M. genavense disease. Of the 12 patients treated, eight (75%) showed a favourable outcome. Four patients died in this study, three despite treatment for M. genavense disease. We conclude that M. genavense is a clinically relevant pathogen in severely immunocompromised patients that causes predominantly disseminated disease with serious morbidity and mortality. M. genavense is increasingly seen among non-HIV immunocompromised patients.
© 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22439918     DOI: 10.1111/j.1469-0691.2012.03817.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  11 in total

1.  Mesenterial involvement of Mycobacterium genavense infection: hard to find, hard to treat.

Authors:  Nasstasja Wassilew; Laura Ciaffi; Alexandra Calmy
Journal:  BMJ Case Rep       Date:  2015-05-14

2.  To Induce Immune Reconstitution Inflammatory Syndrome or Suppress It: The Spectrum of Mycobacterium genavense in the Antiretroviral Era.

Authors:  Maura Manion; Niamh Lynn; Luxin Pei; Dima A Hammoud; Elizabeth Laidlaw; Gregg Roby; Dorinda Metzger; Yolanda Mejia; Andrea Lisco; Adrian Zelazny; Steve Holland; Marie-Louise Vachon; Matthew Scherer; Colm Bergin; Irini Sereti
Journal:  Clin Infect Dis       Date:  2021-01-27       Impact factor: 9.079

3.  Refractory Mycobacterium genavense infection secondary to thymoma-associated endogenous IL-12 inhibitor.

Authors:  Jessie Chen; MaiAnh Nguyen; Elaine Cheong; D Sean Riminton; Stephen Reddel
Journal:  BMJ Neurol Open       Date:  2022-05-18

4.  Inventory study of non-tuberculous mycobacteria in the European Union.

Authors:  Marieke J van der Werf; Csaba Ködmön; Vera Katalinić-Janković; Tiina Kummik; Hanna Soini; Elvira Richter; Dimitrios Papaventsis; Enrico Tortoli; Monique Perrin; Dick van Soolingen; Manca Zolnir-Dovč; Vibeke Ostergaard Thomsen
Journal:  BMC Infect Dis       Date:  2014-02-06       Impact factor: 3.090

5.  Mycobacterium genavense infection in two species of captive snakes.

Authors:  Leila Sabrina Ullmann; Ramiro das Neves Dias-Neto; Didier Quevedo Cagnini; Ricardo Seiti Yamatogi; Jose Paes Oliveira-Filho; Viviane Nemer; Rodrigo Hidalgo Friciello Teixeira; Alexander Welker Biondo; João Pessoa Araújo
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2016-10-18

6.  Disseminated Mycobacterium genavense Infection in Patient with Adult-Onset Immunodeficiency.

Authors:  Takanori Asakura; Ho Namkoong; Takuro Sakagami; Naoki Hasegawa; Kiyofumi Ohkusu; Akira Nakamura
Journal:  Emerg Infect Dis       Date:  2017-07       Impact factor: 6.883

7.  Mycobacterium genavense invading the bone marrow in a HIV-positive patient.

Authors:  Christianne Bourlon; Cesar Vargas-Serafín; Xavier López-Karpovitch
Journal:  Clin Case Rep       Date:  2017-04-26

8.  Acquired and Innate Immunity Impairment and Severe Disseminated Mycobacterium genavense Infection in a Patient With a NF-κB1 Deficiency.

Authors:  Luis Ignacio Gonzalez-Granado; Raquel Ruiz-García; Javier Blas-Espada; José Manuel Moreno-Villares; Marta Germán-Diaz; Marta López-Nevado; Estela Paz-Artal; Oscar Toldos; Yolanda Rodriguez-Gil; Jaime de Inocencio; Nerea Domínguez-Pinilla; Luis M Allende
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

9.  Mycobacterium genavense Infections in a Tertiary Hospital and Reviewed Cases in Non-HIV Patients.

Authors:  M Santos; A Gil-Brusola; A Escandell; M Blanes; M Gobernado
Journal:  Patholog Res Int       Date:  2014-02-19

10.  Mycobacterium Genavense Granuloma Mimicking a Brain Tumor: A Case Report.

Authors:  Atrin Toussi; Amir Goodarzi; Edwin Kulubya; Darrin J Lee; Ben Waldau
Journal:  Cureus       Date:  2017-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.